Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2013
DOI: 10.1021/cb3005353
|View full text |Cite
|
Sign up to set email alerts
|

FluorinatedN,N-Dialkylaminostilbenes Repress Colon Cancer by Targeting MethionineS-Adenosyltransferase 2A

Abstract: Methionine S-adenosyltransferase 2A (MAT2A) is the catalytic subunit for synthesis of S-adenosylmethionine (SAM), the principal methyl donor in many biological processes. MAT2A is up-regulated in many cancers, including liver cancer and colorectal cancer (CRC) and is a potentially important drug target. We developed a family of fluorinated N,N-dialkylaminostilbene agents, called FIDAS agents, that inhibit the proliferation of CRC cells in vitro and in vivo. Using a biotinylated FIDAS analog, we identified the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
60
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
2

Relationship

6
2

Authors

Journals

citations
Cited by 54 publications
(64 citation statements)
references
References 25 publications
2
60
1
Order By: Relevance
“…As desired, these stilbene-based agents did not affect methionine S-adenosyltransferase-1 (MAT1) 1619 that served as the principal source of SAM necessary for other cellular needs. Unlike a recent report 20 of other MAT2A inhibitors, we also demonstrated in vivo potency in a xenograft model using colorectal cancer cells 12 .…”
Section: Introductioncontrasting
confidence: 76%
See 2 more Smart Citations
“…As desired, these stilbene-based agents did not affect methionine S-adenosyltransferase-1 (MAT1) 1619 that served as the principal source of SAM necessary for other cellular needs. Unlike a recent report 20 of other MAT2A inhibitors, we also demonstrated in vivo potency in a xenograft model using colorectal cancer cells 12 .…”
Section: Introductioncontrasting
confidence: 76%
“…Computational modeling studies provided guidance with respect to synthetic design but required experimental confirmation. Prior modeling work and pull-down assays confirmed MAT2A as the sole target of stilbene analogs 12 , but it was important to confirm experimentally that the acetylene analogs, such as phenylethynyl-substituted heterocycles 5 , shared the same target as these stilbene analogs. In support of the binding of phenylethynyl-substituted heterocycles 5 to MAT2A, we synthesized and utilized a biologically active, D-(+)-biotin derivative 6 (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The pose ensemble was filtered to reject poses that did not have sufficient shape complementarity with the active site of the protein. In separate docking runs, the binding poses of the ligand structure were refined by MD simulations followed by free energy calculations using the Sander module from the Amber12 package (91) as previously described (92)(93)(94)(95). The AniA-peptide binding complex was neutralized by adding appropriate counterions and was solvated in a rectangular box of TIP3P (transferable intermolecular potential with 3-points model) water molecules with a minimum solute wall distance of 10 Å (96).…”
Section: Methodsmentioning
confidence: 99%
“…Our past experience along these same lines in developing inhibitors that affect Wnt signaling encouraged these efforts. 10,11 …”
Section: Introductionmentioning
confidence: 99%